Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression

Human Pathology

Volumn 45, Issue 5, 2014, Pages 1092-1099

  Abel, E Jason ^a   Bauman, Tyler M ^a   Weiker, Madelyn ^a   Shi, Fangfang ^a   Downs, Tracy M ^a   Jarrard, David F ^a   Huang, Wei ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Biomarkers; Immunohistochemistry; Multispectral imaging; Recurrence; Renal cell carcinoma

Indexed keywords

BIOMARKERS; IMMUNOHISTOCHEMISTRY; MULTISPECTRAL IMAGING; RECURRENCE; RENAL CELL CARCINOMA;

ANTIGENS, NEOPLASM; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; C-REACTIVE PROTEIN; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTEOMICS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898821360     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.01.008     Document Type: Article

References (31)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. T.J. Dudderidge, K. Stoeber, and M. Loddo et al. Mcm2, Geminin, and Ki67 define proliferative state and are prognostic markers in renal cell carcinoma Clin Cancer Res 11 2005 2510 2517
3. M. Sun, S.F. Shariat, and C. Cheng et al. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review Eur Urol 60 2011 644 661
4. D.L. Rimm C-Path: a Watson-like visit to the pathology lab Sci Transl Med 3 2011 108fs8
5. W.H. Huang, H. Kenneth, and S. Drew A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays Hum Pathol 44 2012 29 38
6. J.R. Srigley, B. Delahunt, and J.N. Eble et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia Am J Surg Pathol 37 2013 1469 1489
7. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti III AJCC cancer staging manual 7th ed 2010 Springer New York 479 489
8. M.H.T. Bui, H. Visapaa, and D. Seligson et al. Prognostic value of carbonic anhydrase IX and Ki67 as predictors of survival for renal clear cell carcinoma J Urol 171 2004 2461 2466
9. M.K. Tollefson, R.H. Thompson, and Y. Sheinin et al. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other Cancer 110 2007 783 790
10. A.S. Parker, B.C. Leibovich, and C.M. Lohse et al. Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma Cancer 115 2009 2092 2103
11. T.V. Johnson, S. Ali, and A. Abbasi et al. Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma J Urol 186 2011 1213 1217
12. S. Biswas, P.J. Charlesworth, and G.D. Turner et al. CD31 angiogenesis and combined expression of HIF-1alpha and HIF-2alpha are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFalpha transcriptional products are not: implications for antiangiogenic trials and HIFalpha biomarker studies in primary CC-RCC Carcinogenesis 33 2012 1717 1725
13. T.M. Nicholson, P.D. Sehgal, and S. Drew et al. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment Differentiation 85 2013 140 149
14. E.J. Chae, J.K. Kim, and S.H. Kim et al. Renal cell carcinoma: analysis of postoperative recurrence patterns Radiology 234 2005 189 196
15. S.E. Eggener, O. Yossepowitch, and J.A. Pettus et al. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence J Clin Oncol 24 2006 3101 3106
16. R.E. Roses, E.C. Paulson, and A. Sharma et al. HER-2/Neu overexpression as a predictor for the transition from in situ to invasive breast cancer Cancer Epidemiol Biomarkers & Prevent 18 2009 1386 1389
17. A. Mishra, and M. Verma Cancer biomarkers: are we ready for the prime time? Cancers (Basel) 2 2010 190 208
18. M.A. Rubin, M. Zhou, and S.M. Dhanasekaran et al. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer J Am Med Assoc 287 2002 1662 1670
19. S.A. Siddiqui, I. Frank, and J.C. Cheville et al. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol BJUI 104 2009 778 785
20. M.H. Tan, H. Li, and C.V. Choong et al. The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma Cancer 117 2011 5314 5324
21. T. Klatte, D.B. Seligson, and J. LaRochelle et al. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy Cancer Epidemiol Biomarkers & Prev 18 2009 894 900
22. A. Di Napoli, and S. Signoretti Tissue biomarkers in renal cell carcinoma: issues and solutions Cancer 115 2009 2290 2297
23. S. Detre, G. Saclani Jotti, and M. Dowsett A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas J Clin Pathol 48 1995 876 878
24. B.A. Gayed, R.F. Youssef, and A. Bagrodia et al. Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma BJU Int 113 4 2014 668 673
25. S. Aaltomaa, P. Lipponen, and M. Ala-Opas et al. Prognostic value of Ki-67 expression in renal cell carcinomas Eur Urol 31 1997 350 355
26. J. Gerdes, H. Lemke, and H. Baisch et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1984 1710 1715
27. S.G. Kroeze, A.M. Bijenhof, and J.L. Bosch et al. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma Cancer Biomark 7 2010 261 268
28. V. Margulis, Y. Lotan, and P.I. Karakiewicz et al. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer J Natl Cancer Inst 101 2009 114 119
29. K. Ito, H. Yoshii, and A. Sato et al. Impact of postoperative C-reactive protein level on recurrence and prognosis in patients With N0M0 clear cell renal cell carcinoma J Urol 186 2011 430 435
30. D.S. Cho, S.J. Kim, and S.H. Lee et al. Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma Korean J Urol 52 2011 104 109
31. M. Gerlinger, A.J. Rowan, and S. Horswell et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892